Saini Arti, Singh Inder, Kumar Mukesh, Radhakrishnan Divya Madathiparambil, Agarwal Ayush, Garg Divyani, Elavarasi Arunmozhimaran, Singh Rahul, Chouhan Vivek, Gupta Anu, Vishnu Venugopalan Yamuna, Singh Mamta Bhushan, Bhatia Rohit, Garg Ajay, Gupta Neerja, Mir Riyaz Ahmad, Faruq Mohammed, Binukumar Balachandran Krishnamma, Srivastava Achal Kumar, Rajan Roopa
Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.
CSIR-Institute of Genomics and Integrative Biology, New Delhi, India.
Mov Disord Clin Pract. 2025 May;12(5):594-601. doi: 10.1002/mdc3.14325. Epub 2025 Jan 3.
Genomic variations associated with dystonia in Asian Indians remain largely unknown.
To identify genomic alterations associated with dystonia in the Asian Indian population using next generation sequencing approaches.
From September 2018 to December 2023, we enrolled 745 individuals including probands with dystonia and family members, in the Indian Movement Disorder Registry and Biobank. Clinical and demographic data were captured on a REDCap platform. We performed whole exome sequencing (WES) on DNA specimens obtained from 267 individuals with isolated, combined or complex dystonia. Variants were classified according to joint guidelines of American College of Medical Genetics and Genomics (ACMG) and Association of Molecular Pathology (AMP).
The mean age of the WES cohort was 33.8 ± 16.2 years, and mean age at onset (AAO) of dystonia was 25.6 ± 17.7 years. 62.2% had isolated dystonia, 7.9% combined and 29.2% had complex phenotypes. WES identified pathogenic/ likely pathogenic variants in 54 patients (20.2%) including 14 novel variants in known dystonia genes. Variants in THAP1 were most common followed by PANK2, GLB1, PLA2G6, TOR1A, ANO3, VPS16, SGCE, SPG7, FTL and other genes. Multifocal/generalized distribution of dystonia [OR: 4.1; 95% CI 1.4-12.2, P = 0.011] and family history [OR: 4.3; 95% CI 2.1-8.9, P < 0.001] were associated with positive yield on WES.
THAP1 was the most frequent dystonia associated gene in this cohort. Singleton WES identifiedpotentially pathogenic variants in approximately one out of five patients tested, and contributed to management decisions in 4%.
亚洲印度人中与肌张力障碍相关的基因组变异在很大程度上仍不为人知。
使用下一代测序方法鉴定亚洲印度人群中与肌张力障碍相关的基因组改变。
2018年9月至2023年12月,我们在印度运动障碍登记处和生物样本库中纳入了745名个体,包括肌张力障碍先证者及其家庭成员。临床和人口统计学数据在REDCap平台上收集。我们对从267名患有孤立性、合并性或复杂性肌张力障碍的个体获得的DNA样本进行了全外显子组测序(WES)。变异根据美国医学遗传学与基因组学学会(ACMG)和分子病理学协会(AMP)的联合指南进行分类。
WES队列的平均年龄为33.8±16.2岁,肌张力障碍的平均发病年龄(AAO)为25.6±17.7岁。其中62.2%患有孤立性肌张力障碍,7.9%为合并性,29.2%具有复杂表型。WES在54名患者(20.2%)中鉴定出致病/可能致病的变异,包括已知肌张力障碍基因中的14个新变异。THAP1基因的变异最为常见,其次是PANK2、GLB1、PLA2G6、TOR1A、ANO3、VPS16、SGCE、SPG7、FTL和其他基因。肌张力障碍的多灶性/全身性分布[比值比(OR):4.1;95%置信区间(CI)1.4 - 12.2,P = 0.011]和家族史[OR:4.3;95% CI 2.1 - 8.9,P < 0.001]与WES的阳性检出率相关。
在该队列中,THAP1是最常见的与肌张力障碍相关的基因。单例WES在约五分之一的检测患者中鉴定出潜在致病变异,并为4%的患者的管理决策提供了依据。